NanoLC-MS/MS Analysis Provides New Insights into the Phosphorylation Pattern of Cdc25B in Vivo: Full Overlap with Sites of Phosphorylation by Chk1 and Cdk1/cycB Kinases in Vitro

Journal of Proteome Research

Volumn 7, Issue 3, 2008, Pages 1264-1273

  Bouché, Jean Pierre ^a,b   Froment, Carine ^b   Dozier, Christine ^a   Esmenjaud Mailhat, Charlotte ^a   Lemaire, Matthieu ^a   Monsarrat, Bernard ^b   Burlet Schiltz, Odile ^b   Ducommun, Bernard ^a  

^a Université de Toulouse Paul Sabatier   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Cdc25b; Cell cycle; Chk1, cdk1; Electrospray; Mass spectrometry; Phosphorylation; Post translational modification

Indexed keywords

CHECKPOINT KINASE 1; CYCLIN DEPENDENT KINASE 1; PROTEIN CDC25B; PROTEIN CDC25B3; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; CDC25B PROTEIN, HUMAN; PROTEIN KINASE;

ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVE SITE; ESCHERICHIA COLI; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NANOANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; AMINO ACID SEQUENCE; CELL LINE; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NANOTECHNOLOGY; PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CDC2 PROTEIN KINASE; CDC25 PHOSPHATASES; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NANOTECHNOLOGY; PHOSPHORYLATION; PROTEIN KINASES; TANDEM MASS SPECTROMETRY;

EID: 44449163559     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr700623p     Document Type: Article

References (78)

1. Mann, M.; Jensen, O. N. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 2003, 21, 255-261.
2. Loyet, K. M.; Stults, J. T.; Arnott, D. Mass spectrometric contributions to the practice of phosphorylation site mapping through 2003: a literature review. Mol. Cell. Proteomics 2005, 4, 235-245.
3. D'Ambrosio, C.; Salzano, A. M.; Arena, S.; Renzone, G.; Scaloni, A. Analytical methodologies for the detection and structural characterization of phosphorylated proteins. J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci. 2007, 849, 163-180.
4. Rossignol, M. Proteomic analysis of phosphorylated proteins. Curr. Opin. Plant Biol. 2006, 9, 538-543.
5. Schmelzle, K.; White, F. M. Phosphoproteomic approaches to elucidate cellular signaling networks. Curr. Opin. Biotechnol. 2006, 17, 406-414.
6. Reinders, J.; Sickmann, A. State-of-the-art in phosphoproteomics, Proteomics 2005, 5, 4052-4061.
7. Goshe, M. B, Characterizing phosphoproteins and phosphoproteomes using mass spectrometry. Brief. Funct. Genomic Proteomics 2006, 4, 363-376.
8. Blomberg, I.; Hoffmann, I. Ectopic expression of Cdc25A accelerates the Gl/S transition and leads to premature activation of cyclin E-and cyclin A-dependent kinases. Mol. Cell. Biol. 1999, 19, 6183-6194.
9. Garner-Hamrick, P. A.; Fisher, C. Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects. J. Cancer 1998, 76, 720-728.
10. Turowski, P.; Franckhauser, C.; Morris, M. C.; Vaglio, P.; Fernandez, A.; Lamb, N. J. Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells. Mol. Biol. Cell 2003, 14, 2984-2998.
11. Donzelli, M.; Draetta, G. F. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep. 2003, 4, 671-677.
12. Lindqvist, A.; Kallstrom, H.; Lundgren, A.: Barsoum, E.; Rosenthal, C. K. Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J. Cell. Biol. 2005, 171, 35-45.
13. Ferguson, A. M.; White, L. S.; Donovan, P. J.; Piwnica-Worms, H. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol. Cell. Biol. 2005, 25, 2853-2860.
14. Mailand, N.; Podtelejnikov, A. V.; Groth, A.; Mann, M.; Bartek, J.; Lukas, J. Regulation of G(2)/M events by Cdc25A through phosphorylation- dependent modulation of its stability. EMBO J. 2002, 21, 5911-5920.
15. Izumi, T.; Mailer, J. L. Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase. Mol. Biol. Cell 1993, 4, 1337-1350.
16. Wang, R.; He, G.; Nelman-Gonzalez, M.; Ashorn, C. L.; Gallick, G. E.; Stukenberg, P. T.; Kirsner, M. W.; Kuang, J. Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell 2007, 128, 1119-1132.
17. Casado-Vela, J.; Ruiz, E. J.; Nebreda, A. R.; Casal, J. I. A combination of neutral loss and targeted product ion scanning with two
18. enzymatic digestions facilitates the comprehensive mapping of phosphorylation sites. Proteomics 2007, 7, 2522-2529.
19. Hassepass, I.; Voit, R.; Hoffmann, I. Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint. J. Biol. Chem. 2003, 278, 29824-29829.
20. Jin, J.; Shirogane, T.; Xu, L; Nalepa, G.; Qin, J.; Elledge, S. J.; Harper, J. W. SCF β-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 2003, 17, 3062-3074.
21. Shimuta, K.; Nakajo, N.; Uto, K.; Hayano, Y.; Okazaki, K.; Sagata, N. Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition. EMBO J. 2002, 21, 3694-3703.
22. Kanemori, Y.; Uto, K.; Sagata, N. Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases, Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 6279-6284.
23. Uto, K.; Inoue, D.; Shimuta, K.; Nakajo, N.; Sagata, N. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism. EMBO J. 2004, 23, 3386-3396.
24. Baldin, V.; Pelpel, K.; Cazales, M. Nuclear localization of CDC25B1 and serine 146 integrity are required for induction of mitosis. J. Biol. Chem. 2002, 277, 35176-35182.
25. Elia, A. E.; Cantley, L. C.; Yaffe, M. B. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science 2003, 299, 1228-1231.
26. Zhao, H.; Watkins, J. L.; Piwnica-Worms, H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 14795-14800.
27. Sorensen, C. S.; Syljuasen, R. G.; Falck, J.; Schroeder, T.; Ronnstrand, L.; Khanna, K. K.; Zhou, B. B.; Bartek, J.; Lukas, J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003, 3, 247-258.
28. Lemaire, M.; Froment, C.; Boutros, R.; Mondesert, O.; Nebreda, A. R.; Monsarrat, B.; Ducommun, B. CDC25B phosphorylation by p38 and MK2. Cell Cycle 2006, 5, 1649-1653.
29. Mirey, G.; Chartrain, I.; Froment, C.; Quaranta, M.; Bouché J.-P.; Monsarrat, B.; Tassan, J. P.; Ducommun, B. CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis. Cell Cycle 2005, 4, 806-811.
30. Theis-Febvre, N.; Filhol, O.; Froment, C.; Cazales, M.; Cochet, C.; Monsarrat, B.; Ducommun, B.; Baldin, V. Protein kinase CK2 regulates CDC25B phosphatase activity. Oncogene 2003, 22, 220-232.
31. Chen, M. S.; Ryan, C. E.; Piwnica-Worms, H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol. Cell. Biol. 2003, 23, 7488-7497.
32. Schmitt, E.; Boutros, R.; Froment, C.; Monsarrat, B.; Ducommun, B.; Dozier, C. CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J. Cell Sci. 2006, 119, 4269-4275.
33. Toyoshima-Morimoto, F.; Taniguchi, E.; Nishida, E. Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep. 2002, 3, 341-348.
34. Bulavin, D. V.; Higashimoto, Y.; Demidenko, Z. N.i Meek, S.; Graves, P.; Phillips, C.; Zhao, H.; Moody, S. A.; Appella, E.; Piwnica-Worms, H.; Fornace, A. J. Jr. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat. Cell Biol. 2003, 5, 545-551.
35. Margolis, S. S.; Perry, J. A.; Weitzel, D. H.; Freel, C. D.; Yoshida, M.; Haystead, T. A.; Kornbluth, S. A Role for PP1 in the Cdc2/Cyclin B-mediated Positive Feedback Activation of Cdc25. Mol. Biol. Cell 2006, 17, 1779-1789.
36. Peng, C. Y.; Graves, P. R.; Thoma, R. S.; Wu, Z.; Shaw, A. S.; Piwnica-Worms, H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277, 1501-1505.
37. Sanchez, Y.; Wong, C.; Thoma, R. S.; Richman, R.; Wu, Z.; Piwnica-Worms, H.; Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997, 277, 1497-1501.
38. Kumagai, A.; Guo, Z.; Emami, K. H.; Wang, S. X.; Dunphy, W. G. The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. J. Cell Biol. 1998, 142, 1559-1569.
39. Matsuoka, S.; Huang, M.; Elledge, S. J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998, 282, 1893-1897.
40. Blasina, A.; de Weyer, I. V.; Laus, M. C.; Luyten, W. H.; Parker, A. E.; McGowan, C. H. A human homologue of the checkpoint kinase Cds1 directly inhibits CDC25 phosphatase. Curr. Biol. 1999, 9, 1-10.
41. Chaturvedi, P.; Eng, W. K.; Zhu, Y.; Mattern, M. R.; Mishra, R.; Hurle, M. R.; Zhang, X.; Annan, R. S.; Lu, Q.; Faucette, L. F.; Scott, G. F.; Li, X.; Carr, S. A.; Johnson, R. K.; Winkler, J. D.; Zhou, B. B. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999, 18, 4047-4054.
42. Peng, C. Y.; Graves, P. R.; Ogg, S.; Thoma, R. S.; Byrnes, M. I., III; Wu, Z.; Stephenson, M. T.; Piwnica-Worms, H. C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ. 1998, 9, 197-208.
43. Bulavin, D. V.; Higashimoto, Y; Popoff, I. J.; Gaarde, W. A.; Basrur, V.; Potapova, O.; Appella, E.; Fornace, A. J., Jr. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001, 411, 102-107.
44. Manke, I. A.; Nguyen, A.; Lim, D.; Stewart, M. Q.; Elia, A. E. H.; Yaffe, M. B. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 2005, 17, 37-48.
45. Duckworth, B. C.; Weaver, J. S.; Ruderman, J. V. G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A. Proc. Natl. Acad. Sci. U.SA. 2002, 99, 16794-16799.
46. Davezac, N.; Baldin, V.; Blot, J.; Ducommun, B.; Tassan, J. P. Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: A potential role for pEg3 in cell cycle regulation. Oncogene 2002, 21, 7630-7641.
47. Eymin, B.; Claverie, P.; Salon, C.; Brambilla, C.; Brambilla, E.; Gazzeri, C. pl4ARF Triggers G2 Arrest Through ERK-Mediated Cdc25C Phosphorylation, Ubiquitination and Proteasomal Degradation. Cell Cycle 2006, 5, 759-765.
48. Schwindling, S. L.; Noll, A.; Montenarh, M.; Gotz, C. Mutation of a CK2 phosphorylation site in cdc25C impairs importin alpha/beta binding and results in cytoplasmic retention. Oncogene 2004, 23, 4155-4165.
49. Baldin, V.; Theis-Febvre, N.; Benne, C.; Froment, C.; Cazales, M.; Burlet-Schiltz, O.; Ducommun, B. PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation. Biol. Cell. 2003, 95, 547-554.
50. Dutertre, S.; Cazales, M.; Quaranta, M.; Froment, C.; Trabut, V.; Dozier, C.; Mirey, G.; Bouché, J.-P.; Theis-Febvre, N.; Schmitt, E.; Monsarrat, B.; Prigent, C.; Ducommun, B. Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J. Cell Sci. 2004, 117, 2523-2531.
51. Giles, N.; Forrest, A.; Gabrielli, B. 14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity. J. Biol. Chem. 2003, 278, 28580-28587.
52. Busino, L.; Donzelli, M.; Chiesa, M.; Guardavaccaro, D.; Ganoth, D.; Dorrello, N. V.; Hershko, A.; Pagano, M.; Draetta, G. F. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 2003, 426, 87-91.
53. van Vugt, M. A.; Bras, A.; Medema, R. H. Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol. Cell 2004, 15, 799-811.
54. Bugler, B.; Quaranta, M.; Aressy, B.; Brezak, M.-C.; Prévost, G.; Ducommun, B. Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. Mol. Cancer Ther. 2006, 5, 1446-1451.
55. Löffler, H.; Rebacz, B.; Ho, A. D.; Lukas, J.; Bartek, J.; Krämer, A. Chkl-Dependent Regulation of Cdc25B Functions to Coordinate Mitotic Events. Cell Cycle 2006, 5, 2543-2547.
56. Bansal, S.;. Lazo, J. S. Induction of Cdc25B regulated cell cycle resumption after genotoxic stress. Cancer Res. 2007, 67, 3356-3363.
57. Davezac, N.; Baldin, V.; Gabrielli, B.; Forrest, A.; Theis-Febvre, N.; Yashida, M.; Ducommun, B. Regulation of CDC25B phosphatases subcellular localization. Oncogene 2000, 19, 2179-2185.
58. van Montfort, B. A.; Canas, B.; Duurkens, R.; Godovac-Zimmermann, J.; Robillard, G. T. Improved in-gel approaches to generate peptide maps of integral membrane proteins with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J. Mass Spectrom. 2002, 37, 322-330.
59. Baldin, V.; Cans, C.; Knibiehler, M.; Ducommun, B. Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation. J. Biol. Chem. 1997, 272, 32731-32734.
60. Songyang, Z.; Blechner, S.; Hoagland, N.; Hoekstra, M. F.; Piwnica-Worms, H.; Cantley, L. C. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol. 1994, 4, 873-982.
61. cdk2. J. Biol. Chem. 1996, 271, 25240-25246.
62. Lammer, C.; Wagerer, S.; Saffrich, R.; Mertens, D.; Ansorge, W.; Hoffmann, I. The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J. Cell. Sci. 1998, 111, 2445-2453.
63. Graves, P. R.; Yu, L.; Schwarz, I. K.; Gales, J.; Sausville, E. A.; O'Connor, P. M.; Piwnica-Worms, H. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 2000, 275, 5600-5605.
64. Kumagai, A.; Dunphy, W. G. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev. 1999, 13, 1067-1072.
65. Yang, J.; Winkler, K.; Yoshida, M.; Kornbluth, S. Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J. 1999, 18, 2174-2183.
66. Zeng, Y.; Piwnica-Worms, H. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol. Cell. Biol. 1999, 19, 7410-7419.
67. Uchida, S.; Kuma, A.; Ohtsubo, M.; Shimura, M.; Hirata, M.; Nakagama, H.; Matsunaga, T.; Ishizaka, Y.; Yamashita, K. Binding of 14-3-3beta but not 14-3-3sigma controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B. J. Cell. Sci. 2004, 117, 3011-3020.
68. Varmeh-Ziaie, S.; Manfredi, J. J. The dual-specificity phosphatase Cdc25B, but not the closely related Cdc25C, is capable of inhibiting cellular proliferation in a manner dependent upon its catalytic activity. J. Biol. Chem. 2007, 282, 24633-24641.
69. Cans, C.; Ducommun, B.; Baldin, V. Proteasome-dependent degradation of human CDC25B phosphatase. Mol. Biol. Rep. 1999, 26, 53-57.
70. Mitra, J.; Enders, G. H. Cyclin A/Cdk2 complexes regulate activation of Cdk1 and CDC25 phosphatases in human cells. Oncogene 2004, 23, 3361-3367.
71. Schulman, B. A.; Lindström, D. L.; Harlow, E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl. Acad. Sci. U.S.A 1998, 95, 10453-10458.
72. Stevenson-Lindert, L. M.; Fowler, P.; Lew, I. Substrate Specificity of CDK2-Cyclin A. What is optimal. J. Biol. Chem. 2003, 278, 50956-50960.
73. Liu, F.; Rothblum-Oviatt, C.; Ryan, C. E.; Piwnica-Worms, H. Overproduction of Human Mytl Kinase Induces a G2 Cell Cycle Delay by Interfering with the Intracellular Trafficking of Cdc2-Cyclin B1 Complexes. Cell. Biol. 1999, 19, 5113-5123.
74. Saha, P.; Eichbaum, Q.; Silberman, E. D.; Mayer, B. J.; Dutta, A. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol. Cell. Biol. 1997, 17, 4338-4345.
75. Cheng, K.-Y.; Noble, M. E. N.; Skamnaki, V.; Brown, N. R.; Lowe, E. D.; Kontogiannis, L.; Shen, K.; Cole, P. A.; Siligardi, G.; Johnson, L. N. The Role of the Phospho-CDK2/Cyclin A Recruitment Site in Substrate Recognition. J. Biol. Chem. 2006, 281, 23167-23179.
76. Dosztányi, Z.; Csizmók, V.; Tompa, P.; Simon, I. IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics 2005,21, 3433-3434.
77. Dyson, H. J.; Wright, P. E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6, 197-208.
78. Forrest, A.; Gabrielli, B. Cdc25B activity is regulated by 14-3-3. Oncogene 2001, 20, 4393-4401.